Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
11/2010
11/10/2010CN101879179A Compound Ofloxacin solution and preparation method thereof
11/10/2010CN101879177A Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale
11/10/2010CN101396524B Oral preparation for treating chronic bronchitis
11/10/2010CN101342275B Medicament for preventing and controlling aspergillus disease of chicken
11/10/2010CN101332280B Traditional Chinese medicine paster for treating chronic pharyngitis and preparation method thereof
11/10/2010CN101279029B Liquid oral vaccine for curing blue-ear pig disease and method of preparing the same
11/10/2010CN101278923B Potassium sodium dehydroandroan drographolide succinate microcapsule and method for preparing injection thereof
11/10/2010CN101264239B Externally-applied powdered Chinese medicine for treating chronic sinusitis and nasal polyps and preparation thereof
11/10/2010CN101244049B Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof
11/10/2010CN101214295B Medicament for treating chicken infectivity laryngotracheitis
11/10/2010CN101181556B Chinese medicine prescription orally taken for curing chronic bronchitis
11/10/2010CN101181352B Chinese medicine preparation for curing acute rhinitis and preparation method thereof
11/10/2010CN101167839B Fagopyrum cymosum compound preparation for treating and preventing chronic obstructive lung disease and use
11/10/2010CN101161264B A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction
11/10/2010CN101104031B Internal-applied traditional Chinese medicine composition for treating nasopharyngeal cancer
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829596 administering to the patient an effective amount of a xanthine oxidase inhibitor ( allopurinol, 7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, leukopterin, xanthopterin, neopterin etc.) to reduce sympathetic nervous system activity and/or improving cardiovascular reflex status for treating cachexia
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829102 Both human and bovine polynucleotide sequences, as well as a major nucleocapsid (N) protein, a nucleocapsid phosphoprotein (P), a large polymerase protein (L), and a RNA polymerase elongation factor combined with heterologous gene(s)
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010US7827986 Methods for treating jaw pain
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2438544C Aerosol compositions containing formoterol for delivery to the lungs via nebulization
11/09/2010CA2397583C New aminopropylphosphinic acids
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010127108A2 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126025A1 Quaternary ammonium salt compound
11/04/2010WO2010126022A1 Imidazole derivative
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125445A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010WO2010125082A1 Oxazole substituted indazoles as pi3-kinase inhibitors
11/04/2010WO2010124618A1 Use of cell autophagy (type ii cell apoptosis) inhibitors
11/04/2010WO2010103362A3 Process for the preparation of bosentan
11/04/2010WO2010078419A3 Herbal-based nasal solution and method of use thereof
11/04/2010WO2010076566A3 Indoles useful in the treatment of inflammation
11/04/2010US20100280113 Compositions and methods for the treatment of cystic fibrosis
11/04/2010US20100280087 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
11/04/2010US20100280086 Substituted thiophenes
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280062 (e)-n--methanesulfonamide as glucocorticoid receptor modulator for the treatment of rheumatoid arthritis
11/04/2010US20100280059 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100280053 CyclopropylmethYl-[7-(5,7-dimethyl-benzo[1,2,5]thiodiazol-4-yl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-4-propyl-amine as a CRF Antagonist
11/04/2010US20100280052 Use of antivirals to treat cmv-related conditions
11/04/2010US20100280049 Antagonists of pgd2 receptors
11/04/2010US20100280048 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
11/04/2010US20100280045 Novel compounds
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280029 Novel compounds
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280007 Pyridazinone Derivatives
11/04/2010US20100280001 Imidazoquinolines with immuno-modulating properties
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279975 Compounds and methods associated with differential methylation of human papilloma virus genomes in epithelial cells
11/04/2010US20100279958 Compounds and methods for inhibiting selectin-mediated function
11/04/2010US20100279925 Airway Administration of Site-Inactived FVIIA in Inflammatory Conditions Affecting the Respiratory Tract
11/04/2010US20100279924 Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
11/04/2010US20100279922 Melanocortin Receptor Ligands
11/04/2010US20100279919 Compositions comprising human integrin-linked kinase-sirna and methods of use thereof
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100279327 Method of treating diseases with parp inhibitors
11/04/2010US20100278929 Antibody formulations having optimized aggregation and fragmentation profiles
11/04/2010US20100278915 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010US20100278907 Immunogenic Compositions Containing Ceramide and Methods of Use Thereof
11/04/2010US20100278901 Compositions and methods of making rapidly dissolving ionically masked formulations
11/04/2010US20100278838 Epha2 monoclonal antibodies and methods of use thereof
11/04/2010US20100278835 Novel compounds 660
11/04/2010US20100278813 Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278781 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
11/04/2010US20100275913 Composition for inhalation
11/04/2010CA2760689A1 Compositions comprising an antihistamine, antitussive and decongestant in extended release formulations
11/04/2010CA2760630A1 Quaternary ammonium salt compounds
11/04/2010CA2760253A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010CA2759476A1 Novel compounds
11/04/2010CA2757761A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/03/2010EP2246360A1 Compositions for the treatment of gastrointestinal disorders
11/03/2010EP2246344A1 Pyrimidine compounds and medicinal composition thereof
11/03/2010EP2246336A1 Fibrosis inhibitor
11/03/2010EP2245038A1 New macrolides and their use
11/03/2010EP2245030A1 Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
11/03/2010EP2245026A1 Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
11/03/2010EP2244692A2 Inhalation drug products, systems and uses
11/03/2010EP2010498B1 Synthesis of acylaminoalkenylene amides useful as substance p antagonists
11/03/2010EP1496838B1 Substituted amides
11/03/2010EP1404302B1 Pharmaceutical compositions comprising adsorbates of amorphous drug
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010CN1973850B Medicine composition for treating allergic rhinitis and its preparation process
11/03/2010CN1951390B Pharmaceutical compositions comprising colloidal silicon dioxide
11/03/2010CN1927303B Chinese medicine for treating chicken respiratory tract disease
11/03/2010CN1872075B Drop pills of hemsleyadin, and preparation method
11/03/2010CN1872062B Fibrauretine, and preparation method
11/03/2010CN1857593B Cough-treating preparation
11/03/2010CN101878221A Novel glucocorticoid receptor agonists
11/03/2010CN101874882A Strong loquat leaf extract (blended with honey) and preparation method thereof
11/03/2010CN101874880A Method for preparing traditional Chinese medicine for treating pediatric wind-heat lung obstruction type pneumonia asthma
1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 878